v1
Pembrolizumab en 1 re ligne et atézolizumab en 2 e ligne du CBNPC métastatique
Identifier:nobleid.org/w1/20260515/FDF78B84
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/FDF78B84)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims
Paper Authors